PHP
AXSM icon

Parkman Healthcare Partners’s Axsome Therapeutics AXSM Stock Holding History

Parkman Healthcare Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
+10,000
New +$2.17M 0.25% 69
2021
Q1 		– Sell
-30,758
Closed -$2.51M – 86
2020
Q4 		$2.51M Sell
30,758
-4,252
-12% -$318K 0.64% 53
2020
Q3 		$2.49M Sell
35,010
-4,990
-12% -$389K 0.66% 52
2020
Q2 		$3.29M Buy
+40,000
New +$3.08M 0.93% 40

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Parkman Healthcare Partners's AXSM Position: Q2 2026 in Review

Parkman Healthcare Partners opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 10,000 shares worth $2.45M. The stake represents 0.25% of the portfolio and ranks #69 among its holdings. This is a return to the name: Parkman Healthcare Partners previously reported a position in AXSM as recently as Q4 2020.

Parkman Healthcare Partners first reported a position in AXSM in Q2 2020 and has held it in 4 quarters since. The position peaked at $3.29M in Q2 2020. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Parkman Healthcare Partners held 10,000 shares of Axsome Therapeutics worth $2.45M as of Q2 2026.
  • Axsome Therapeutics was a new Parkman Healthcare Partners position in Q2 2026.
  • Axsome Therapeutics made up 0.25% of Parkman Healthcare Partners's portfolio in Q2 2026, its #69 holding.
  • Parkman Healthcare Partners first reported a position in Axsome Therapeutics in Q2 2020 and has held it in 4 quarters since.
  • Parkman Healthcare Partners's Axsome Therapeutics position peaked at $3.29M in Q2 2020.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.